Do you know obesity is a complex chronic disease that accumulates extra fat deposits inside your body? These fats further lead to multiple real-time problems for the human body. In our innovative world, most people are suffering from extra fat deposits in their body areas like the belly, underarms, shoulders, legs, and neck area. These fat deposits are the result of bad eating habits and a diet full of fat and oils. Mixing food with junk causes the reason that these people suffer from obesity and they do not find any solution for it.
Most people go for surgical options, but most of the time these types of options need post-care and bed rest. After these types of harsh surgeries, patients need more time to recover back to normal life.
Easy Solution For Weight Loss
Worldwide, people who are suffering from obesity are looking for a safe solution or any safe method that helps them remove extra fat deposits from their body effortlessly with less downtime and anything which is non-surgical or minimally surgical. Over the years, worldwide scientists have been trying to make medicine for weight loss that goes inside the body in the form of an injectable. This would be easy for people to take, work immediately, and have fewer side effects.
Mounjaro by Eli Lilly
The company has a leading name worldwide in the health care sector, making life-saving drugs that are helping people to live longer, healthier, and happier lives. In May 2022, the product’s active ingredient, tirzepatide, was approved by the U.S. Food and Drug Administration (FDA) and is also marketed under the name Mounjaro.
What is Mounjaro tirzepatide Injection?
Mounjaro is a once-weekly injection containing the active ingredient tirzepatide. What sets it apart from some other weight loss injections is that it is a dual agonist, meaning it mimics two naturally occurring hormones in the body: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). While many other weight loss injections only work on GLP-1, Mounjaro’s action on both GIP and GLP-1 receptors is believed to lead to greater weight loss.
Mounjaro Price in Pakistan – Dose by Dose Estimate
| Dose (Weekly) | Price for Monthly Supply (4 Pens) | Price per Pen (Weekly) |
|---|---|---|
| 2.5 mg | PKR 70,000 – 110,000 | PKR 17,500 – 27,500 |
| 5 mg | PKR 110,000 – 190,000 | PKR 27,500 – 47,500 |
| 7.5 mg | PKR 140,000 – 230,000 | PKR 35,000 – 57,500 |
| 10 mg | PKR 170,000 – 280,000 | PKR 42,500 – 70,000 |
| 12.5 mg | PKR 200,000 – 330,000 | PKR 50,000 – 82,500 |
| 15 mg | PKR 230,000 – 400,000 | PKR 57,500 – 100,000 |
What is the dosage criteria of Mounjaro?
The Mounjaro dosage criteria depend on many factors in Pakistan. It all depends on your BMI, body type, previous modalities you have used for weight loss, your blood sugar level, and many other factors that your doctor may assess during the consultation. Therefore, before starting this product, a detailed consultation with a professional doctor is a must to achieve the desired results.
How Mounjaro Injection Works?
By mimicking GLP-1 and GIP hormones, Mounjaro helps regulate blood sugar and appetite. It works in a few key ways:
• It sends signals to the brain that make you feel less hungry and reduce cravings.
• It slows down how quickly your stomach empties, which helps you feel fuller for a longer period.
• The GIP component may also help prevent fat from building up, enhancing the overall weight loss effect.
Obesity is a complex, chronic disease defined by an excessive accumulation of body fat that poses a significant risk to health, typically measured by a Body Mass Index (BMI) of 30 or higher.
How Mounjaro Works For Weight Loss?
Clinical trials have shown that Mounjaro can lead to substantial weight loss. In one head-to-head trial, people on tirzepatide (the active ingredient in Mounjaro) lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% for those on semaglutide (Wegovy). Another study found that some patients could achieve at least a 20% weight loss after about 18 months of use, in combination with diet and exercise.
What is the difference between Mounjaro and other popular weight loss injections like Wegovy?
A: The main difference lies in their active ingredients and how they work.
• Mounjaro contains tirzepatide, a dual GLP-1 and GIP receptor agonist.
• Wegovy contains semaglutide, which is a GLP-1 receptor agonist only. Because Mounjaro targets both hormones, studies have shown it can result in a greater percentage of body weight loss compared to Wegovy.
Side effects of Mounjaro?
The most common side effects of Mounjaro are related to the digestive system and include nausea, diarrhea, decreased appetite, vomiting, constipation, and stomach pain. These side effects are often mild and tend to be more prevalent when a person first starts the medication or has a dose increase.
Serious side effects Mounjaro
Mounjaro has some serious potential side effects and is not suitable for everyone.
• Serious Side Effects: Rare but serious side effects can include severe digestive problems, pancreatitis (inflammation of the pancreas), gallbladder problems, and acute kidney injury.
• Boxed Warning: Mounjaro has a boxed warning for the risk of thyroid cancer, as studies in animals have shown a link. The risk in humans is unknown, but it should not be used in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Contraindications: Mounjaro should not be used by individuals with a known allergy to tirzepatide or its ingredients. It should be used with caution in people with a history of pancreatitis, severe kidney disease, or diabetic retinopathy.
